MilliporeSigma  

Burlington,  MA 
United States
http://www.SigmaAldrich.com

• Booth: 233

MilliporeSigma, the life science business of Merck KGaA, Darmstadt, Germany, develops innovative, quality high-tech products in healthcare, life science and performance materials. With deep expertise in filtration, reagents, culture, biomarker and cell analysis, MilliporeSigma provides advancements for basic and applied research and manufacturing.

 Press Releases

• MilliporeSigma opened a biosafety testing facility (Nov 07, 2024)
  MilliporeSigma opened a €290M facility in Maryland for biosafety testing, analytical development, and cell banking services.

• MilliporeSigma achieved EXCiPACT cGMP cert (Nov 07, 2024)
  MilliporeSigma achieved EXCiPACT cGMP certification for Pharmaceutical Auxiliary Materials at its global Cell Culture Media sites, being the first in the industry.

• ​​​​​​​MilliporeSigma acquired Mirus Bio (Nov 07, 2024)
  MilliporeSigma acquired Mirus Bio for $600M, enhancing its viral vector manufacturing capabilities and supporting cell and gene therapies.

 Products